carbapenems has been researched along with nalidixic acid in 2 studies
| Studies (carbapenems) | Trials (carbapenems) | Recent Studies (post-2010) (carbapenems) | Studies (nalidixic acid) | Trials (nalidixic acid) | Recent Studies (post-2010) (nalidixic acid) |
|---|---|---|---|---|---|
| 7,355 | 147 | 5,277 | 3,246 | 87 | 340 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Armaki, MT; Gholinia, H; Halaji, M; Hosseini, A; Nasrollahian, S; Pournajaf, A; Rajabnia, M; Teimourian, M | 1 |
| Grafl, B; Hess, C; Hess, M; Maegdefrau, M | 1 |
2 other study(ies) available for carbapenems and nalidixic acid
| Article | Year |
|---|---|
Genetic Diversity, Carbapenem Resistance Genes, and Biofilm Formation in UPEC Isolated from Patients with Catheter-Associated Urinary Tract Infection in North of Iran.
Topics: Anti-Bacterial Agents; Anti-Infective Agents; beta-Lactamases; Biofilms; Carbapenems; Catheters; Cross-Sectional Studies; Edetic Acid; Genetic Variation; Humans; Iran; Nalidixic Acid; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
Topics: Aminoglycosides; Animals; Anti-Bacterial Agents; Carbapenems; Cephalosporins; Chloramphenicol; Colistin; Drug Resistance, Multiple; Enrofloxacin; Flavobacteriaceae Infections; Nalidixic Acid; Ornithobacterium; Oxacillin; Poultry Diseases; Tetracyclines; Turkeys; Tylosin | 2022 |